Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation

Leukemia. 2005 Sep;19(9):1673-5. doi: 10.1038/sj.leu.2403889.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Benzamides
  • Chromosome Aberrations*
  • Chromosomes, Human, Pair 16 / genetics*
  • Exons
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics*
  • Male
  • Middle Aged
  • Mutation
  • Neoplasm, Residual
  • Piperazines / therapeutic use*
  • Proto-Oncogene Proteins c-kit / genetics*
  • Pyrimidines / therapeutic use*
  • Recurrence
  • Remission Induction

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-kit